scholarly journals Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines

Oncogene ◽  
2008 ◽  
Vol 27 (19) ◽  
pp. 2737-2745 ◽  
Author(s):  
H Sasaki ◽  
J Hayakawa ◽  
Y Terai ◽  
M Kanemura ◽  
A Tanabe-Kimura ◽  
...  
PLoS ONE ◽  
2017 ◽  
Vol 12 (9) ◽  
pp. e0185111 ◽  
Author(s):  
Vijayalakshmi N. Ayyagari ◽  
Paula L. Diaz-Sylvester ◽  
Tsung-han Jeff Hsieh ◽  
Laurent Brard

2020 ◽  
Vol 16 (5) ◽  
pp. 524
Author(s):  
Rajeswary Hari ◽  
Priyadurairaj ◽  
PalagatiRohith Kumar Reddy ◽  
Palaniyandi Thiruvanavukkarasu ◽  
Sindhu Rajesh ◽  
...  

2017 ◽  
Vol 41 (18) ◽  
pp. 10438-10446
Author(s):  
E. Tsovaltzi ◽  
E. Malamidou-Xenikaki ◽  
P. Dalezis ◽  
A. Hatzidimitriou ◽  
T. Lazarides ◽  
...  

Piano-stool Ru(ii) complexes incorporating 2-hydroxymethylidene-indene-1,3-dione ligands exhibit promising anticancer activity against four human ovarian cancer cell lines.


1999 ◽  
Vol 73 (1) ◽  
pp. 27-34 ◽  
Author(s):  
Judith K. Wolf ◽  
Tae-Eung Kim ◽  
Diane Fightmaster ◽  
Diane Bodurka ◽  
David M. Gershenson ◽  
...  

1994 ◽  
Vol 93 (6) ◽  
Author(s):  
IngoB. Runnebaum ◽  
Xiao-Wen Tong ◽  
Volker Moebus ◽  
Volker Heilmann ◽  
DirkG. Kieback ◽  
...  

1986 ◽  
Vol 35 (3) ◽  
pp. 467-472 ◽  
Author(s):  
Karen G. Louie ◽  
Thomas C. Hamilton ◽  
Margaret A. Winker ◽  
Brent C. Behrens ◽  
Takashi Tsuruo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document